D-1276-2019 Class II Terminated
FDA drug recall D-1276-2019 was initiated by American Health Packaging on Apr 8, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero. The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 2,203 cartons (cartons of 30 individual unit doses).
Recall details
- Product Type
- Drugs
- Report Date
- May 8, 2019
- Initiation Date
- Apr 8, 2019
- Termination Date
- Nov 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,203 cartons (cartons of 30 individual unit doses)
Product description
GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21
Reason for recall
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
Distribution pattern
Nationwide in the USA
Code information
Lot # 181288, EXP 5/31/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1276-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026